0001562180-24-004437.txt : 20240528
0001562180-24-004437.hdr.sgml : 20240528
20240528160151
ACCESSION NUMBER: 0001562180-24-004437
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Brian Lee
CENTRAL INDEX KEY: 0001847811
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38148
FILM NUMBER: 24991629
MAIL ADDRESS:
STREET 1: 5322 W. BRIAR PARK ROAD
CITY: HERRIMAN
STATE: UT
ZIP: 84096
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Co-Diagnostics, Inc.
CENTRAL INDEX KEY: 0001692415
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 462609396
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4049 SOUTH HIGHLAND DRIVE
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84124
BUSINESS PHONE: 8012789769
MAIL ADDRESS:
STREET 1: 4049 SOUTH HIGHLAND DRIVE
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-05-23
false
0001692415
Co-Diagnostics, Inc.
CODX
0001847811
Brown Brian Lee
C/O CO-DIAGNOSTICS, INC.
2401 S. FOOTHILL DRIVE, SUITE D
SALT LAKE CITY
UT
84109
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-05-23
4
A
false
113334.00
0.00
A
326554.00
D
Common Stock
2024-05-23
4
D
false
35865.00
1.09
D
290689.00
D
Restricted Stock Unit
0.00
2024-05-23
4
M
false
113334.00
0.00
D
Common Stock
628334.00
515000.00
D
Included in 100,000 restricted stock units awarded to the Reporting Person on August 12, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2021. Included in 225,000 restricted stock units awarded to the Reporting Person on June 6, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022. Included in 130,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 23, 2023. Included in 225,000 restricted stock units awarded to the Reporting Person on May 15, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2023.
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
/s/ Brian L. Brown
2024-05-28